Evidence map›Paper›PMID 32729273›Full record

Trial reportKorean journal of radiology2020

Effects of Remote Ischemic Pre-Conditioning to Prevent Contrast-Induced Nephropathy after Intravenous Contrast Medium Injection: A Randomized Controlled Trial.

Dihia Belabbas, Caroline Koch, Ségolène Chaudru, Mathieu Lederlin, Bruno Laviolle, Estelle Le Pabic, Dominique Boulmier, Jean François Heautot, Guillaume Mahe

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Korean journal of radiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02470247 (IPC-Angio Trial), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02470247 nacompletednot on this map

IPC-Angio Trial : Interest of Remote Ischemic Preconditioning for Prevention of Contrast Medium-induced Nephropathy (Post-diagnostic Imaging) in Patients at High Risk of Contrast-induced Nephropathy

TypeinterventionalSponsorRennes University HospitalRan2015 to 2020Enrolled26ConditionsNephropathyArmsRemote Ischemic Preconditioning (RIPC), SHAM Remote Ischemic Preconditioning (SHAM RIPC)
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Dihia BelabbasVascular Medicine Unit, Department of Radiology, University Hospital Pontchaillou, Rennes, France.ORCID 0000-0002-3825-3762
Caroline KochDepartment of Radiodology, Toulouse University Hospital, Toulouse, France.
Ségolène ChaudruVascular Medicine Unit, Department of Radiology, University Hospital Pontchaillou, Rennes, France.
Mathieu LederlinVascular Medicine Unit, Department of Radiology, University Hospital Pontchaillou, Rennes, France.ORCID 0000-0003-1388-5277
Bruno LaviolleVascular Medicine Unit, Department of Radiology, University Hospital Pontchaillou, Rennes, France.ORCID 0000-0002-9541-6708
Estelle Le PabicVascular Medicine Unit, Department of Radiology, University Hospital Pontchaillou, Rennes, France.
Dominique BoulmierVascular Medicine Unit, Department of Radiology, University Hospital Pontchaillou, Rennes, France.
Jean François HeautotVascular Medicine Unit, Department of Radiology, University Hospital Pontchaillou, Rennes, France.
Guillaume MaheVascular Medicine Unit, Department of Radiology, University Hospital Pontchaillou, Rennes, France. maheguillaume@yahoo.fr.ORCID 0000-0003-1318-4745
Hôpital Pontchaillou · FRUniversité Fédérale de Toulouse Midi-Pyrénées · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe aimed to assess the effects of remote ischemic pre-conditioning (RIPC) on the incidence of contrast-induced nephropathy (CIN) after an intravenous (IV) or intra-arterial injection of contrast medium (CM) in patient and control groups. MATERIALS AND

methodsThis prospective, randomized, single-blinded, controlled trial included 26 patients who were hospitalized for the evaluation of the feasibility of transcatheter aortic valve implantation and underwent investigations including contrast-enhanced computed tomography (CT), with Mehran risk scores greater than or equal to six. All the patients underwent four cycles of five minute-blood pressure cuff inflation followed by five minutes of total deflation. In the RIPC group (n = 13), the cuff was inflated to 50 mm Hg above the patient's systolic blood pressure (SBP); in the control group (n = 13), it was inflated to 10 mm Hg below the patient's SBP. The primary endpoint was the occurrence of CIN. Additionally, variation in the serum levels of cystatin C was assessed.

resultsOne case of CIN was observed in the control group, whereas no cases were detected in the RIPC group (

conclusionThe risk of CIN after an IV injection of CM is very low in patients with Mehran risk score greater than or equal to six and even in the patients who are unable to receive preventive hyperhydration. Hence, the Mehran risk score may not be an appropriate method for the estimation of the risk of CIN after IV CM injection.

Indexed as

Acute Kidney InjuryAdministration, IntravenousAgedAged, 80 and overBlood PressureContrast MediaCreatinineCystatin CFemaleHumansIschemic PreconditioningMaleProspective StudiesRisk FactorsSingle-Blind MethodTomography, X-Ray ComputedContrast MediaCreatinineCST3 protein, humanCystatin CAcute kidney injuryContrast mediaIschemic preconditioningNephropathy

Identifiers

PMID32729273
PMCPMC7462761
OpenAlexW3045962542

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.